Company

Product

Description

Indication

Status


Dare Bioscience Inc., of San Diego

DARE-BV1

Thermosetting hydrogel containing clindamycin phosphate 2%

Bacterial vaginosis

FDA granted qualified infectious disease product designation

Proqr Therapeutics NV, of Leiden, the Netherlands

QR-1123

Antisense targeting rhodopsin mRNA

Autosomal dominant retinitis pigmentosa

FDA cleared IND for study of up to 12 patients measuring the restoration or improvement of visual function and retinal structure by visual acuity, visual field and optical coherence tomography


Notes

For more information about individual companies and/or products, see Cortellis.

 

No Comments